The virus that causes COVID-19 continues to mutate. Scientists say that's likely to continue indefinitely, and the virus will ...

“The effectiveness of the COVID vaccines can vary depending on which variants are targeted in the vaccine, which variants are circulating, and host factors,” said Shirin A. Mazumder, MD, and ...

Imunon has reported new immunogenicity and safety data from its proof-of-concept Phase I trial’s ongoing analyses of the IMNN ...

With the rise of omicron came the fall of long-lasting protection from reinfection with the pandemic coronavirus SARS-CoV-2, according to a study published in Nature. Using population-wide data ...

Five years after the COVID-19 pandemic began, the virus continues to spread around the globe as the virus continues to evolve. Scientists say that's likely to continue indefinitely, as the virus finds ...

The virus that causes COVID-19 has been very good at mutating to keep infecting people—so good that most antibody treatments ...

Monoclonal antibodies like etesevimab have lost efficacy against Omicron subvariants, necessitating innovative solutions.

For some, the symptoms never went away. The omicron relative now dominant in the U.S. is called XEC, which accounted for 45% of variants circulating nationally in the two-week period ending Dec ...

When Neil and Michelle went looking for their first house together, they fell for one with a big kitchen addition. The home inspector found no major issues and, reassured, they bought the house. That ...

New Covid variant JN.1 becomes the most common strain on Earth - symptoms to look out for ...

Invivyd (IVVD) announced positive, continued, clinically meaningful in vitro neutralization data for PEMGARDA against the currently dominant ...